Escolar Documentos
Profissional Documentos
Cultura Documentos
Oxford, UK
International
IJD
Blackwell
0011-9059
XXX
Publishing
Journal Ltd,
Ltd
of Dermatology
2007
Yetunde M. Olumide, MD, Ayesha O. Akinkugbe, MD, Dan Altraide, MD, Tahir Mohammed,
MD, Ngozi Ahamefule, MD, Shola Ayanlowo, MD, Chinwe Onyekonwu, MD,
and Nyomudim Essen, MD
Abstract
Skin lightening (bleaching) cosmetics and toiletries are widely used in most African countries.
The active ingredients in these cosmetic products are hydroquinone, mercury and
corticosteroids. Several additives (conconctions) are used to enhance the bleaching effect.
Since these products are used for long duration, on a large body surface area, and under hot
humid conditions, percutaneous absorption is enhanced. The complications of these products
are very serious and are sometimes fatal. Some of these complications are exogenous
ochronosis, impaired wound healing and wound dehiscence, the fish odor syndrome,
nephropathy, steroid addiction syndrome, predisposition to infections, a broad spectrum of
cutaneous and endocrinologic complications of corticosteroids, including suppression of
hypothalamic-pituitary-adrenal axis. In this era of easy travels and migration, African patients
with these complications can present to physicians anywhere in the world. It is therefore critical
for every practicing physician to be aware of these complications.
344
Olumide et al.
Ingredients
Movate
Crusader
Looking Good
Peauclair
Mic
Tura
Betamethasone dipropionate
Vitamed B3 toner 2%, Escalol UV 507, Vit E Allantoin
2% hydroquinone, Allantoin, Sunscreen, Vit E
Hydroquinone, Clobetasol propionate
Hydroquinone, Dimethicone, D-methyl-PABA
Octyl-Dimethyl PABA, Dimethicone,
Aqua glyceryl, propylene glycol mubbery
A-hydroxyl acids, methyl p-ben
Vitamed B3 toner 2%, Escalol UV 507, Vit E Allantoin
Benzophone 3-Dimethicone, Cyclomethicone
Triethanolamine, Carbomer, Dimethicone
Betamethasone dipropionate
Triethanolamine
Natural Essences from botany
2% hydroquinone padimate
2% hydroquinone Octisalate
2% hydroquinone, Vit E 1.0
Clobetasol propionate 0.05
Stearic Acid, MPG, Sorbitol Jelly, Fragrance
A3
Ultra
Venus
Swiss collagen
Fashion Fair
IKB
Shirley
Ambi
Skin Success
Sivoclaire
Fashoin Fair
Tony Montana
345
346
Olumide et al.
25
Hydroquinone (mg%)
Mercury (mg/kg)
Looking Good
Movate
Crusader
Sivoclaire
Peauclaire
Mercury
Mic
Tura
A3
1.36
5.10
3.45
0.06
0.06
1.68
0.06
1.45
0.42
0.17
0.20
0.26
0.22
0.21
0.82
0.22
0.23
0.18
Olumide et al.
347
348
Olumide et al.
Olumide et al.
Mercury
59,60
Cutaneous
Atrophy of the skin (thinning and fine wrinkling)
Telangiectasia, purpura, persistent erythema
Skin fragility
Hypertrichosis
Perioral dermatitis
Pustular acneiform eruption (face) steroid rosacea
Folliculitis
Striae
Hypopigmentation
Steroid addiction syndrome
Predisposition and masking of cutaneous infection
(e.g. Tinea incognito, multiple filiform warts)
Allergic contact dermatitis
Ophthalmologic
Glaucoma
Cataracts
Endocrinologic
Cushingoid syndrome with moon facies,
buffalo humps, supraclavicular fat pads
Hyperglycaemia and diabetes mellitus
Suppression of hypothalamic-pituitary-adrenal axis
Suppression of growth in children
Menstrual irregularities
Edema
Electrolyte imbalance
Hypertension
Pseudotumor cerebri
Others
Aseptic necrosis of the head of femur
Predisposition to infection
Protein catabolism with negative nitrogen balance
Weakness, vertigo
Thrombophlebitis
Osteoporosis
histology. The skin lightening properties of these preparations have been found to be directly proportional to their
vasoconstrictor (blanching) effect.
Fluocinonide (Topsyn gel), Betamethasone dipropionate
(Diprosone), and Clobetasol propionate (Temovate) rate as
some of the strongest topical corticoids, and are among the
commonly used bleaching agents in Nigeria. They are readily
available in the market place among the battery of bleaching creams. When used as cosmetics, they are applied over
a large surface area for prolonged periods several months
to years. This factor, coupled with the occlusive effect of
environmental heat and humidity, promote percutaneous
absorption, and hence, complications. The possible complications of chronic corticosteroid use are shown in Table 3.
All these complications have been observed among chronic
bleachers in Nigeria.23,24,3135 Figs 714 show some of the
complications of long-term use of topical corticosteroids
as skin lightening cosmetics. The lower part of the axilla is
a favored site for steroid folliculitis (Fig. 7) and both sides
International Journal of Dermatology 2008, 47, 344 353
349
350
Olumide et al.
Olumide et al.
351
352
Olumide et al.
Olumide et al.
18 Tidman MJ, Horton JJ, MacDonald DM. Hydroquinoneinduced ochronosis light and electron-microscopic
features. Clin Exp Dermatol 1986; 11: 224228.
19 Hoshaw RA, Zimmerman KG, Menter A. Ochronosislike
pigmentation from hydroquinone bleaching creams
in American blacks. Arch Dermatol 1985; 121: 105108.
20 Lawrence N, Reed R, Perret WJ, et al. Exogenous ochronosis
in the United States. J Am Acad Dermatol 1988; 18: 1207
1222.
21 Brauer EW. Safety of over-the-counter hydroquinone
bleaching creams. [letter]. Arch Dermatol 1985; 121: 1239.
22 Boyle J, Kennedy CTC. Hydroquinone concentrations in
skin lightening creams. Br J Derm 1986; 114: 502504.
23 Olumide YM. Cosmetic Hazards and Legislative Needs in
Nigeria. Nig Med Prac 1985; 9: 712.
24 Olumide YM. Abuse of Topical corticosteroids in Nigeria.
Nig. Med. Pract 1986; 11: 1712.
25 Olumide YM, Elesha SO. Hydroquinone induced
exogenous ochronosis. Nig Med Pract 1986; 11: 103106.
26 Olumide YM. Photodermatoses in Lagos. Int J Dermatol
1987; 26: 295299.
27 Olumide YM. Contact leukoderma. Nig Quart J Hosp
Medical 1989; 4: 5362.
28 Olumide YM. A Pictorial Self-Instructional Manual on
Common Skin Diseases. Nigeria: Heinemann Ibadan, 1990.
29 Olumide YM, Odunowo BD, Odiase AO. Regional
dermatoses in the African I. Facial hypermelanosis. Int J
Dermatol 1991; 30: 186189.
30 Cosmetic Product Regulations (Prohibition of bleaching
agents etc). Extraordinary Federal Republic Nigeria Official
Gazette 1995; 82 (31c).
31 Olumide YM. Cosmetic habits and Legislative need in
Nigeria. Paper presented at NAFDAC Workshop on
Cosmetics Safety Issues, 2002.
32 Adebajo SB. An Epidemiological Survey of the Use of
Cosmetic Skin Lightening Cosmetics among Traders in
Lagos. Nigeria. Personal Communication.
33 Ofondu EO. Cosmetic use of bleaching creams in Enugu.
Nigerian FMCP Dissertation, 2003.
34 Lerner AB, Fitzpatrick TB. Inhibition of melanin formation
by chemical agents. J Invest Dermatol 1952; 18: 119135.
35 Jimbow K, Obata H, Pathak MA, et al. Mechanism of
Depigmentation by Hydroquinone. J Invest Dermatol 1974;
62: 436.
36 Findlay GH. Ochronosis following skin bleaching with
hydroquinone (Editorial). J Am Acad Dermatol 1982; 6:
10921093.
37 Goldsmith LA. Cutaneous changes in errors of amino acid
metabolism: alkaptonuria. In: Fitzpatrick TB, Eisen AZ,
Wolff K, Freedberg IM, Austen KF, eds. Dermatology in
General Medicine, Chap 148. New York: McGraw-Hill,
1993: 18411845.
38 Jackyk WK. Annular granulomatous lesions in exogenous
ochronosis are manifestations of sarcoidosis. Am J
Dermatopathol 1995; 17: 1822.
39 Jordaan HF, Van Niekerk DJT. Transepidermal elimination
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
353